Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma

BACKGROUND: Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune responses, it is possible that antibodies could also mediate protection against S...

Descripción completa

Detalles Bibliográficos
Autores principales: Tso, For Yue, Lidenge, Salum J., Poppe, Lisa K., Peña, Phoebe B., Privatt, Sara R., Bennett, Sydney J., Ngowi, John R., Mwaiselage, Julius, Belshan, Michael, Siedlik, Jacob A., Raine, Morgan A., Ochoa, Juan B., Garcia-Diaz, Julia, Nossaman, Bobby, Buckner, Lyndsey, Roberts, W. Mark, Dean, Matthew J., Ochoa, Augusto C., West, John T., Wood, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932539/
https://www.ncbi.nlm.nih.gov/pubmed/33661923
http://dx.doi.org/10.1371/journal.pone.0247640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932539/
https://www.ncbi.nlm.nih.gov/pubmed/33661923
http://dx.doi.org/10.1371/journal.pone.0247640

Ejemplares similares